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Metrics typically used to report the performance of an
early warning score (EWS), such as the area under the
receiver operator characteristic curve or C-statistic, are
not useful for pre-implementation analyses. Because
physiological deterioration has an extremely low
prevalence of 0.02 per patient-day, these metrics can
be misleading. We discuss the statistical reasoning
behind this statement and present a novel alternative
metric more adequate to operationalize an EWS. We
suggest that pre-implementation evaluation of EWSs
should include at least two metrics: sensitivity; and
either the positive predictive value, number needed to
evaluate, or estimated rate of alerts. We also argue the
importance of reporting each individual cutoff value.who may well have the disease or condition in question.Introduction
Metrics typically used to report the performance of an early
warning score (EWS), such as the area under the receiver
operator characteristic curve (AUROC), C-statistic, likeli-
hood ratio, or specificity, are not adequate for an oper-
ational evaluation in a clinical setting because they do not
incorporate information about prevalence of the disease.
These metrics are being used to drive decisions regarding
which EWS to implement as part of the afferent limb of
rapid response systems. The metrics have been used exten-
sively in pre-implementation evaluations, both in peer-
reviewed publications [1, 2] and in guidelines [3]. Some of
these evaluations have led to the recommendation of the
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already being used in many hospitals [5–7].
These metrics are accepted and widely used to evalu-
ate all types of diagnostic tools, and they are very useful
in evaluating most other tools. The C-statistic, AUROC,
specificity, or likelihood ratio are only dependent on the
test and are not influenced by the pre-test probability
(generally assumed to be equal to the prevalence). Using
these metrics is generally useful for two reasons. First,
pre-test probability may vary widely in the patients on
which a physician decides to perform the diagnostic test.
Since test assessors do not know which patients will
undergo the test, it makes sense to leave that unknown
out of the equation when evaluating the test. Second,
the pre-test probability is usually in a clinically plausible
range, and most clinical tests are performed on patients
EWSs are a special type of diagnostic tool, however,
which makes these classic metrics not ideal. EWSs try to
predict a condition whose prevalence is known to be less
than 2 % [8, 9] in general care inpatients. As a result,
these metrics (AUROC, C-statistic, specificity, likelihood
ratio) provide incomplete information and can lead to
overestimating the benefits of an EWS or underestimat-
ing the cost in terms of clinical resources.Prevalence is important
Performing diagnostic tests when the pre-test probability
is low is accepted practice. We test for phenylketonuria
in newborns and for HIV in blood samples from US
blood donors, both conditions with an estimated pre-
test probability of 0.0001 [10, 11].
Trying to predict events such as these with extremely
low prevalence is justified when: 1) the event has severe
consequences and the consequences increase if missed for
a period of time; and 2) when the test administered is rela-
tively easy and cheap to perform. Systems using EWSs to
try to detect or predict physiological deterioration haveccess article distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in any
ly credited. The Creative Commons Public Domain Dedication waiver (http://
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ation typically have more severe consequences if treat-
ment is delayed (e.g., sepsis and other causes of shock,
respiratory insufficiency, etc.). In addition, the marginal
cost of calculating a patient’s EWS is very small for paper-
based EWSs, but even more so for automated EWSs em-
bedded in the electronic medical record.
When the prevalence is very low, however, even
“good” tests have surprisingly low post-test probability.
The following example involved one of the authors of
this article. Twenty years ago, an 18 year old donated
blood and was told by letter that her HIV enzyme-linked
immunosorbent assay (ELISA) test was repeatedly react-
ive while her western blot was indeterminate. When the
author tried to determine the probability that she actu-
ally had HIV, he found that even though ELISA tests for
HIV are extremely accurate, the pre-test probability (at
that time) that an 18-year-old female college student
was actually infected with HIV was 0.0002 [12]. Hence,
because of the extremely low pre-test probability, even a
positive result on a test with almost 100 % sensitivity
and 99.5 % specificity [12–14] (which is equivalent to a
positive likelihood ratio of 200) meant that, considering
the test results, the probability that this woman was ac-
tually infected with HIV was only around 4 %.
Most EWS operate in a low-prevalence
environment
Why is prevalence so important? The positive predictive
value (PPV) can be expressed as a function with a direct
relationship to prevalence:
PPV ¼ Sensitivity  prevalence
Sensitivity  prevalenceþ 1−specificityð Þ  1−prevalenceð Þ½ 
As prevalence decreases, so does the PPV. The post-
test probability depends on the pre-test probability.
Prevalence, here and in the rest of our article, refers to
the pre-test probability, or the prevalence of the disease in
the subset of patients in which the test is administered.
Figure 1 demonstrates this function for a sensitivity of
99 % and specificities of 99 % and 96 %. Even with such
extremely high sensitivity and specificity, it is easy to see
how the PPV declines rapidly for pre-test probabilities
<0.1. This means that for pre-test probabilities <0.1, a test
with a high sensitivity and specificity may not necessarily
produce a high post-test probability for a positive test.
In this setting, the sensitivity and specificity could in-
form what score and cutoff value performs better, but
the magnitude of the difference could be very mislead-
ing. For example, for a sensitivity of 99 % and a preva-
lence of 0.02 outcomes per patient-day (as discussed
previously, similar to the prevalence of physiological de-
terioration in inpatient populations in general care beds),
reducing the specificity by only 3 % would halve thePPV to 33 % (see Fig. 1). The C-statistic or AUROC is
perhaps the most commonly used metric in the EWS lit-
erature, especially in studies comparing different scores
[15, 16]. The AUROC can be understood as the prob-
ability that a higher score distinguishes between two pa-
tients, one with the outcome and one without the
outcome. Some of the limitations of using the AUROC
for models predicting risk have been discussed previ-
ously [17]. We also previously showed how some scores
with high AUROC did not perform well under simula-
tion of clinical use using PPV as a metric [8]. In addition
to lacking information about disease prevalence, the
AUROC has the additional problem of summarizing in-
formation about different cutoff values, some of which
will never be used because of unacceptably high false-
positive rates. It is important to evaluate and report ac-
tionable cutoff values independently.
Accordingly, reliance only on metrics such as the C-stat-
istic [15, 16] or the AUROC can offer misleading reassur-
ance. We argue that in these settings it is better to report
metrics which incorporate the pre-test probability.
What metrics should we use?
If the commonly used metrics (sensitivity, specificity, like-
lihood ratio, and derived measures like the C-statistic or
AUROC) do not seem to provide useful information to
evaluate EWSs, what can be used instead? Patients who
score above a threshold usually undergo further evaluation
(a “workup”), so limiting false alerts is critical to avoid
alarm fatigue [18, 19] and overuse of clinical resources.
Ideally, reports on the performance of EWSs would in-
clude information about both goals of the EWS: detecting
a high percentage of outcomes, and issuing few false-
positive alerts. This makes a tradeoff evident: the benefit
of the system is the early detection, and the main burden
or cost is the false-positive alerts. To evaluate the first aim
(the benefit), sensitivity can be a good metric because it
provides the percentage of outcomes that the score is able
to predict within a specified timeframe. To evaluate the
second aim (the clinical burden), there are a few metrics
that can be used. These metrics include the PPV, the num-
ber needed to evaluate (NNE), also known as the workup
to detection (WTD) ratio, and the estimated rate of alerts.
The PPV would provide the percentage of alerts that
are followed by an outcome within a certain number of
hours. This tells us the percentage of alerts which are
useful in that they precede an outcome. To use the PPV
effectively we need to overcome some preconceptions
about what is a good PPV. In a classic diagnostic tool, a
PPV lower than 50 % is generally unacceptable, because
this would mean that one-half of the people with a positive
test result would be incorrectly classified as having the
condition. In an EWS, however, this only means having to
perform further workup on two patients for each outcome
Fig. 1 PPV as a function of prevalence for two sample scores (EWS): score A (blue), with a sensitivity of 99 % and a specificity of 99 %; and score
B (red), with a sensitivity of 99 % and a specificity of 96 %. a Full range of possible PPV and prevalence, from 0 to 1. b Region of prevalence <0.1,
adding a line to show an example prevalence of 0.02 (corresponding to an estimate of the rate of physiological deterioration of inpatients). A
decrease of only 3 % in specificity can mean a 50 % decrease in PPV: from 0.33 to 0.66
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predict severe outcomes that can often result in death, and
only requires a brief assessment to confirm or discard the
“diagnosis” of physiological deterioration (Fig. 2a).
The NNE (using parallelism with the number needed
to treat) is the number of patients that it is necessary to
further evaluate (or workup) to detect one outcome. It is
a direct measure of the cost-efficiency of each alert. A
PPV of 20 % is equivalent to an NNE of 5 (Fig. 2b).
The estimated rate of alerts provides the estimated
number of alerts (workups needed) per unit of time per
number of inpatients monitored. For example, one can
estimate the number of alerts per day per 100 inpatients.
This can guide discussions with practicing providers.
Once an EWS is in place, the number of alerts can be
“titrated” by changing the alert threshold. Based on our
experience, there seems to be a “sweet spot” in the num-
ber of daily alerts: too many will create alarm fatigue,
but too few can lead to unfamiliarity with the clinical re-
sponse workflow (Fig. 2c).
Graphic representation
Figure 2 uses two sample scores (Red EWS and Blue
EWS) to exemplify use of the recommended principlesand metrics, and to illustrate some of the recommenda-
tions and warnings. As can be seen in Fig. 2d, the Red
EWS has a higher AUROC of 0.93, as compared with an
AUROC of 0.88 for the Blue EWS, which might lead to
choosing the Red EWS over the Blue EWS. However, we
can see that the other metrics tell a different story, and
offer more important information about the conse-
quences of using the scores. If we look at Fig. 2a, we can
see that the maximum PPV of the Red EWS is only
about 11 % at a sensitivity of 85 % (Point A), so a clin-
ician would need to respond to 16 calls per day for every
100 patients (Fig. 2c) and for every nine patients evalu-
ated only one would be a true positive (NNE = 9; see
Fig. 2b). This is likely to disrupt the clinical workflow
significantly and create alarm fatigue. The Blue EWS, on
the other hand, for a slightly lower sensitivity of 70 %,
has a PPV of 30 % (Point B). This would create six alerts
per day for every 100 patients, and one in every three
alerts would be a true positive (NNE = 3; see Fig. 2b). So
when comparing Points A and B, a tradeoff is evident:
Point A (Red EWS) has a sensitivity 21 % higher (85 %
vs. 70 %), but the rate of alerts is 166 % higher (16 per
day vs. 6 per day). The Blue EWS offers a more manage-
able and useful prediction. In general, if the receiver
Fig. 2 Graphic representations of the proposed metrics and the ROC
curves for all cutoff values of two sample scores (EWS). a, b, c Three
proposed metrics for the two sample scores. d ROC curves which we
suggest not using. Each point in the graphs corresponds to a threshold
of a specific score. Points A and B are referred to in the text. AUROC area
under the receiver operator characteristics, EWS early warning score,
NNE number needed to evaluate, PPV positive predictive value
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EWSs intersect, even the score with the lowest AUROC
may perform better in certain circumstances.
Additional considerations
In addition to what metrics to use, there are some
additional aspects to be considered when evaluating a
specific EWS.
The likelihood ratio can also be considered for the
evaluation of an EWS. Likelihood ratios are the multi-
plier that needs to be applied to the pre-test odds to cal-
culate the post-test odds (the positive or negative
likelihood ratio in the case of a positive or a negative re-
sult in the test, respectively). These ratios are one step
closer to providing a clear cost–benefit analysis, because
they only need to be multiplied by a prevalence or event
rate to provide an estimation of cost in terms of false
alerts. However, they still do not make the tradeoff
evident.
Metrics that focus on missed events, such as the nega-
tive predictive value, are mainly useful if the intended
use of the EWS is to rule out the possibility of physio-
logical deterioration. This does not seem to be the
current intended use, which, rather, is to add “an add-
itional layer of early detection” [4, 20].
Reclassification indices can also be considered. These
indices can offer good comparisons between two differ-
ent scores, by showing how many additional patients
would be correctly classified as having an event or not
when one score is used over another. However, reclassi-
fication indices are limited in that they are only able to
compare scores one-to-one, and they provide only com-
parisons, not results in absolute terms: a score may cor-
rectly classify double the number of patients, but this
does not mean the resulting PPV will be actionable.
Reclassification indices do not allow for direct evaluation
of the tradeoff between detection and false alerts in ab-
solute terms.
Just as the measures used to evaluate a diagnostic test
(e.g., to measure the accuracy of a specific HIV diagnos-
tic test) are different from the evaluation of the strategy
(answering the question “does testing blood for HIV
reduce infections?”), the pre-implementation metrics
discussed in this paper (aimed at evaluating the accuracy
of the EWS) are different from post-implementation
“success measures” of the strategy (aimed at answering
the question “does the use of EWS improve patient
outcomes?”).
EWSs are really trying to predict instances of physio-
logical deterioration. Surrogate measures of physiological
deterioration include ICU transfers and cardiorespiratory
arrests, and some authors also include the calls to the
rapid response team. These proxy outcomes vary locally
by hospital and patient population, but they are within the
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this article still hold true despite those variances. We
nonetheless recommend reporting the prevalence of
physiological deterioration in studies comparing EWSs.
Our article assumes selection of a threshold to trigger
an escalation of care. Threshold selection has been de-
scribed as a function of the test’s properties (sensitivity
and specificity), the prevalence of the condition, and the
benefit or harm of identifying or missing the diagnosis
of a condition [21]. Different hospitals may have differ-
ent priorities or constraints that may affect any of these
variables, but we believe the metrics should make evi-
dent the tradeoff between detection of physiological de-
terioration and the practice constraints.
Final remarks
We have discussed the limitations of metrics that do not
incorporate information regarding prevalence. In broader
terms, we can divide metrics into two groups. First, a
group that focuses on the ranking of scores that does not
take clinical utility into consideration, using metrics
widely used in statistical science to evaluate other types of
classification systems (e.g., systems used in credit card
fraud [22] or the prognosis of alcoholic hepatitis [23]).
Second, another group that is specific to the problem of
operationalizing EWS and tries to predict the operational
consequences related to using one score over another.
In the first group we find the aforementioned metrics
(sensitivity, specificity, likelihood ratios, or AUROC),
while in the second group we find metrics such as the
PPV or the NNE.
To compare EWSs it is important to report metrics
that incorporate the extremely low prevalence. We rec-
ommend using the PPV, the NNE and/or the estimated
rate of alerts combined with sensitivity to evaluate each
of the plausible score cutoff values. Including two of
these metrics in a graph allows for easy evaluation of
practical clinical usefulness both in absolute terms and
for comparison of two or more EWSs. Evaluating EWSs
in this way demonstrates the balance between the bene-
fit of detecting and treating very sick patients with the
associated clinical burden on providers and patients.
Clinically, EWSs should not replace clinical judgment
and decision-making but should serve as a safety net.
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